STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.91
+1.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.15x
- Price / sales
- 0.94x
- Price / cash flow
- -15.94x
Enterprise value
- Enterprise value
- $216.4M
- EV / sales
- 1.40x
- EV / EBITDA
- -10.94x
- EV / EBIT
- -9.47x
- Market cap
- $145.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026